Related Experiment Videos
[Ischemic heart disease].
1Department of Laboratory Medicine, Kochi Medical School, Nankoku 783-8505.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|June 22, 2005
Summary
Acute coronary syndrome, a leading cause of death, requires prompt reperfusion. Advanced cardiac biomarkers and electrocardiograms aid in diagnosing acute myocardial infarction and guiding treatment for better outcomes.
Area of Science:
- Cardiology
- Biomedical Engineering
Context:
- Ischemic heart disease is a major cause of mortality in Japan.
- Acute coronary syndrome (ACS) often results from atherosclerotic plaque rupture and thrombus formation.
- Early and complete reperfusion is critical for treating acute coronary occlusion.
Purpose:
- To highlight the importance of diagnostic tools in acute myocardial infarction (AMI).
- To discuss the evolving role of cardiac biomarkers, particularly troponins, in AMI diagnosis.
- To emphasize the continued significance of electrocardiograms in identifying high-risk patients and assessing AMI severity.
Summary:
- Diagnosis of AMI has evolved from symptoms and enzyme levels to highly sensitive and specific tests, especially cardiac biomarkers like troponins, per new ESC/ACC criteria.
- Electrocardiograms remain crucial for AMI diagnosis and risk stratification.
- The 'no reflow' phenomenon, where blood flow is impeded post-occlusion relief, necessitates assessment of coronary microvascular injury using methods like myocardial scintigraphy.
Impact:
- Improved diagnostic accuracy for AMI through advanced biomarkers and ECG interpretation.
- Better identification of high-risk patient subgroups for timely intervention.
- Enhanced treatment decisions for improving microvascular and left ventricular function post-angioplasty by assessing coronary perfusion and microvascular injury.